Skip Navigation
Skip to contents

KSC 2018

일정표

Home > Program > 일정표
  • Scientific Session [Boehringer Ingelheim/Lilly]
  • New Horizons in Treatment of Heart Failure
  • Apr. 22 (Sat.) 12:15-12:55, Rm.214
  • Chairpersons: 정명호, 강석민
12:15 - 12:30

Empagliflozin’s WIN Against a Formidable Foe, "Heart Failure with Preserved Ejection Fraction"

[Speaker] 오재원 / 연세의대

12:30 - 12:45

Should Empagliflozin Be Used Against Chronic Heart Failure Regardless of LVEF?

[Speaker] 조재영 / 전남의대

12:45 - 12:55

Discussion